文献速递产科母胎医学

孕前贫血与美国孕产妇严重并发症相关:基于大型队列的二次分析

Maternal anemia and severe maternal morbidity in a US cohort.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-05-13

该研究基于美国19家医院2002—2008年228,438例分娩的数据库进行二次分析,纳入166,566例单胎活产孕妇,其中6.1%产前诊断贫血。校正混杂因素后,贫血与孕产妇严重并发症复合结局(aOR 2.04,95%CI 1.86–2.23)及新生儿复合结局(aOR 1.14,95%CI 1.06–1.23)独立相关。

要点

  • 产前贫血孕妇发生严重孕产妇并发症的风险约为无贫血者的2倍(aOR 2.04)。
  • 贫血还与输血、子宫切除、ICU入住、产后出血及感染等单项不良结局相关。
  • 新生儿复合不良结局风险轻度升高(aOR 1.14),提示需关注围产儿结局。

核心结论

  • 产前诊断贫血的孕妇发生严重孕产妇并发症及其他严重不良结局的风险显著升高。
  • 产前识别并治疗贫血可能有助于识别和管理孕产妇发病和死亡高风险人群。

研究设计与样本

  • 本研究为基于Consortium on Safe Labor数据库的二次分析,该数据库收集了2002—2008年美国19家医院的228,438例分娩数据。
  • 分析纳入单胎活产妊娠,排除死胎和严重先天畸形;最终166,566例符合纳入标准,其中10,217例(6.1%)产前诊断贫血。
  • 贫血诊断通过电子病历摘录和ICD编码获得,比较贫血组与非贫血组的孕产妇和新生儿结局。

主要发现

  • 贫血组孕妇更年轻、非西班牙裔黑人比例更高、单身、多产及孕前BMI更高。
  • 校正混杂因素后,贫血与严重孕产妇并发症复合结局独立相关(aOR 2.04;95%CI 1.86–2.23)。
  • 贫血还与不包括输血的严重孕产妇并发症复合结局、孕产妇死亡、血栓形成、输血、子宫切除、ICU入住、产后出血、妊娠期高血压疾病、剖宫产及感染性疾病相关。
  • 新生儿复合结局在校正混杂因素后仍与贫血相关(aOR 1.14;95%CI 1.06–1.23)。

关键数值与推荐

  • 主要孕产妇结局为CDC定义的严重孕产妇并发症复合结局,包括孕产妇死亡、子痫、血栓形成、输血、子宫切除及孕产妇ICU入住。
  • 主要新生儿结局为复合结局,包括5分钟Apgar评分<7、缺氧缺血性脑病、呼吸窘迫综合征、坏死性小肠结肠炎、惊厥、颅内出血、脑室周围或脑室内出血、新生儿败血症、新生儿ICU入住及新生儿死亡。
  • 多因素logistic回归纳入组间差异P<.05的潜在混杂变量。

临床怎么用

  • 产科医生应重视产前贫血的筛查与诊断,将其作为严重孕产妇并发症的风险标志。
  • 对产前贫血孕妇应加强监测和干预,以降低严重孕产妇发病和死亡风险。

局限性

  • 本研究为二次分析,原始数据库收集于2002—2008年,结论外推需谨慎。
  • 56,734例因贫血诊断未知被排除,可能存在选择偏倚。
  • 贫血诊断基于病历摘录和ICD编码,可能存在错分偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal anemia is a common pregnancy complication and often leads to a requirement for additional treatments and interventions. Identifying the frequency at which women with antenatally diagnosed anemia experience severe morbidity at the time of admission to the labor and delivery unit will guide future recommendations regarding screening and interventions for anemia during pregnancy. OBJECTIVE: The objective of this study was to evaluate the association between antenatally diagnosed anemia and severe maternal morbidity as defined by the Centers for Disease Control and Prevention in a large, contemporary, US cohort. Neonatal outcomes were also examined. STUDY DESIGN: This was a secondary analysis of the Consortium on Safe Labor database from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, which collected data on 228,438 deliveries in 19 United States hospitals from 2002 to 2008. This analysis included women with viable, singleton gestations and excluded stillbirths and gestations with severe congenital anomalies. Women with a diagnosis of antenatal anemia were compared with those without. Identification of diagnoses of antenatal anemia was obtained via electronic medical record abstraction and International Classification of Diseases coding according to each hospital protocol within the Consortium on Safe Labor. The primary maternal outcome consisted of a composite of severe maternal morbidity as defined by the Centers for Disease Control and Prevention and included maternal death, eclampsia, thrombosis, transfusion, hysterectomy, and maternal intensive care unit admission. The primary neonatal outcome was a composite that included a 5-minute Apgar score of <7, hypoxic ischemic encephalopathy, respiratory distress syndrome, necrotizing enterocolitis, seizures, intracranial hemorrhage, periventricular or intraventricular hemorrhage, neonatal sepsis, neonatal intensive care unit admission, and neonatal death. Each outcome within the composites was assessed individually along with other additional secondary outcomes, including a composite of severe maternal morbidity not including transfusion morbidity. All statistical analyses were performed with Stata version 14.2 (StataCorp LLC, College Station, TX) using Student's t test, chi-square test, Fisher's exact test, and Wilcoxon rank-sum (Mann-Whitney U) test, as appropriate. A multivariable logistic regression was performed with potential confounding variables entered into the regression equation if they differed between groups at a significance level of P<.05. RESULTS: A total of 166,566 women met the inclusion criteria. From the original cohort, 56,734 women could not be included because of an unknown diagnosis of anemia. Of those included, 10,217 (6.1%) were diagnosed with anemia during the pregnancy. Women with anemia were more likely to be younger, non-Hispanic Black, single, multiparous, and have a higher prepregnancy body mass index than those without anemia. The frequency of the primary maternal composite outcome, the neonatal composite outcome, and other secondary outcomes including the severe maternal morbidity composite not including transfusion, maternal death, transfusion during labor and the postpartum period, hysterectomy, postpartum hemorrhage, infectious morbidity, cesarean delivery, and preterm delivery were more common in women with anemia (P<.05). After multivariable logistic regression analysis adjusting for confounders, higher rates of severe maternal morbidity remained persistently associated with anemia (adjusted odds ratio, 2.04; 95% confidence interval, 1.86-2.23) in addition to the association of anemia with the severe maternal morbidity composite not including transfusion, maternal death, thrombosis, transfusion, hysterectomy, intensive care unit admission, postpartum hemorrhage, hypertensive disorders of pregnancy, cesarean delivery, and infectious morbidity. The composite neonatal outcome also remained associated with anemia after adjusting for confounders (adjusted odds ratio, 1.14; 95% confidence interval, 1.06-1.23). CONCLUSION: Women with antepartum anemia experienced increased rates of severe maternal morbidity and other serious adverse outcomes. Diagnosis and treatment of anemia during the antepartum period may lead to the identification and treatment of women at higher risk for maternal morbidity and mortality.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Harrison RK, Lauhon SR, Colvin ZA, et al. Maternal anemia and severe maternal morbidity in a US cohort. Am J Obstet Gynecol MFM. 2021. PMID: 33992832. doi:10.1016/j.ajogmf.2021.100395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。